Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 0.6680
-0.0940 (-12.34%)
Mar 2, 2026, 3:14 PM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 49.83 million as of March 2, 2026. Its market cap has decreased by -73.84% in one year.
Market Cap
49.83M
Enterprise Value
43.26M
Revenue
3.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
Market Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has increased from 35.83M to 49.83M, an increase of 39.08%. That is a compound annual growth rate of 3.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 49.83M | -65.03% |
| Dec 30, 2025 | 142.46M | -29.89% |
| Dec 30, 2024 | 203.19M | 77.51% |
| Dec 29, 2023 | 114.47M | 308.04% |
| Dec 30, 2022 | 28.05M | -83.60% |
| Dec 30, 2021 | 171.01M | -12.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.71B |
| Orexo AB | 990.58M |
| Cinclus Pharma Holding AB | 811.62M |
| Nanexa AB | 655.87M |
| Dicot Pharma AB | 599.79M |
| Moberg Pharma AB | 486.46M |
| Enzymatica AB | 475.76M |
| Klaria Pharma Holding AB (publ.) | 201.21M |